SMLR - Major Acquisition Alert: William Chang Acquires $268K In Semler Scientific Stock Options | Benzinga
In a recent SEC filing, it was disclosed that William Chang, Director at Semler Scientific (NASDAQ:SMLR), made a noteworthy acquisition of company stock options on May 29,.
What Happened: Chang, Director at Semler Scientific, engaged in a derivative transaction according to a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission. This involved the acquisition of stock options for 27,000 shares of SMLR, providing the right to purchase the company's stock at an exercise price of $23.32 per share.
The Thursday morning market activity shows Semler Scientific shares up by 3.13%, trading at $33.25. This implies a total value of $268,110 for Chang's 27,000 shares.
All You Need to Know About Semler Scientific
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Semler Scientific: Financial Performance Dissected
Revenue Challenges: Semler Scientific's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the ...